Fig 6. Differences in baseline characteristics of NEDA compared to EDA patients.

(a) Scatter plots showing the baseline percentage of T helper and (b) NK cells expressing the activation marker HLA-DR (mean and SD) in patients with no evidence of disease activity (NEDA) and in patients with evidence of disease activity (EDA) (n = 19). (c) The number (x10⁶/L) of terminally differentiated effector memory (TEMRA) T helper cells at baseline and after one year in NEDA and EDA patients.